|
VPS54 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.833800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.282600E-01 |
| Normal-vs-Stage2 |
8.389400E-01 |
| Normal-vs-Stage3 |
9.804600E-03 |
| Normal-vs-Stage4 |
1.055990E-03 |
| Stage1-vs-Stage2 |
9.718200E-01 |
| Stage1-vs-Stage3 |
8.179400E-03 |
| Stage1-vs-Stage4 |
1.260070E-03 |
| Stage2-vs-Stage3 |
1.852390E-01 |
| Stage2-vs-Stage4 |
8.046400E-02 |
| Stage3-vs-Stage4 |
4.770200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.016300E-02 |
| Normal-vs-AfricanAmerican |
2.136000E-01 |
| Normal-vs-Asian |
1.935620E-01 |
| Caucasian-vs-AfricanAmerican |
8.933400E-01 |
| Caucasian-vs-Asian |
1.432400E-01 |
| AfricanAmerican-vs-Asian |
8.811700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.430300E-02 |
| Normal-vs-Female |
8.263800E-01 |
| Male-vs-Female |
1.330060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.122400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.285400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.128550E-01 |
| Normal-vs-Age(81-100Yrs) |
1.703770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.215650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.460010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.054400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.862800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.911800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.937600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.167200E-01 |
| Normal-vs-Grade 2 |
9.726000E-01 |
| Normal-vs-Grade 3 |
2.922200E-02 |
| Normal-vs-Grade 4 |
5.85679999999256E-05 |
| Grade 1-vs-Grade 2 |
2.013200E-01 |
| Grade 1-vs-Grade 3 |
2.827600E-02 |
| Grade 1-vs-Grade 4 |
7.570200E-04 |
| Grade 2-vs-Grade 3 |
1.098370E-02 |
| Grade 2-vs-Grade 4 |
1.94383999999603E-05 |
| Grade 3-vs-Grade 4 |
1.422040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.635210E-01 |
| Normal-vs-ccB subtype |
1.342310E-03 |
| ccA subtype-vs-ccB subtype |
4.14419999983373E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.939640E-01 |
| Normal-vs-N1 |
1.496410E-02 |
| N0-vs-N1 |
1.799810E-01 |
|
|
